These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Risk management in a polio-free world. Bruce Aylward R; Sutter RW; Cochi SL; Thompson KM; Jafari H; Heymann D Risk Anal; 2006 Dec; 26(6):1441-8. PubMed ID: 17184391 [TBL] [Abstract][Full Text] [Related]
3. Combined use of inactivated and oral poliovirus vaccines in a large-scale campaign in refugee camps and host communities – Kenya, December 2013. Wkly Epidemiol Rec; 2014 Mar; 89(12):127-32. PubMed ID: 24707518 [No Abstract] [Full Text] [Related]
5. [Worldwide eradication of poliomyelitis]. Rasch G; Schreier E; Kiehl W; Kurth R Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120 [TBL] [Abstract][Full Text] [Related]
6. Poliomyelitis vaccines in Belgium: 20 years of experience. Andre FE Dev Biol Stand; 1979; 43():187-93. PubMed ID: 230109 [No Abstract] [Full Text] [Related]
7. Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. Wkly Epidemiol Rec; 2010 Jun; 85(23):213-28. PubMed ID: 20545051 [No Abstract] [Full Text] [Related]
8. World could be declared free of polio by 2018. Gulland A BMJ; 2013 Apr; 346():f2373. PubMed ID: 23585234 [No Abstract] [Full Text] [Related]
9. Polio eradication in India: how far are we from reaching the goal? Banerjee K; Sahu S; Bandyopadhyay S Indian J Pediatr; 2001 Mar; 68 Suppl 1():S6-14. PubMed ID: 11411387 [No Abstract] [Full Text] [Related]
10. On reducing the risk of vaccine-associated paralytic poliomyelitis in the global transition from oral to inactivated poliovirus vaccine. Peng X; Hu X; Salazar MA Lancet; 2018 Aug; 392(10147):610-612. PubMed ID: 29605427 [No Abstract] [Full Text] [Related]
11. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis. Pliaka V; Kyriakopoulou Z; Markoulatos P Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246 [TBL] [Abstract][Full Text] [Related]
12. Benefits and risks of attenuated polio vaccine strains in a community immunized with inactivated polio vaccine. Rossier E; Phipps PH; Pépin O Dev Biol Stand; 1979; 43():179-85. PubMed ID: 520669 [No Abstract] [Full Text] [Related]
13. Public health. Is polio eradication realistic? Arita I; Nakane M; Fenner F Science; 2006 May; 312(5775):852-4. PubMed ID: 16690846 [No Abstract] [Full Text] [Related]
15. [Vaccination against poliomyelitis. Formation of immunity evaluated according to the results of serological surveys]. Zabicka J Przegl Epidemiol; 1981; 35(3):385-9. PubMed ID: 6276928 [No Abstract] [Full Text] [Related]
16. [Problems of prevention and control of poliomyelitis in Poland]. Mazurowska-Magdzik W; Bucholc B; Janaszek-Seydlitz W; Szkoda T; Magdzik W Przegl Epidemiol; 2010; 64(3):341-7. PubMed ID: 20976944 [TBL] [Abstract][Full Text] [Related]
17. Safe landing for global polio eradication: a perspective. Arita I; Francis DP Vaccine; 2011 Nov; 29(48):8827-34. PubMed ID: 21959326 [TBL] [Abstract][Full Text] [Related]
18. OPV cannot eradicate polio from India: do we need any further evidence? Paul Y Vaccine; 2008 Apr; 26(17):2058-61. PubMed ID: 18378367 [TBL] [Abstract][Full Text] [Related]
19. [Poliomyelitis vaccination in Denmark]. Petersen I Ugeskr Laeger; 1985 Jan; 147(4):265-9. PubMed ID: 3976028 [No Abstract] [Full Text] [Related]
20. Polio eradication. Looking for a little luck. Roberts L Science; 2009 Feb; 323(5915):702-5. PubMed ID: 19197035 [No Abstract] [Full Text] [Related] [Next] [New Search]